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Abstract
Background: The COVID-19 pandemic has had a great im-
pact on cognitive health in Latin American older adults, in-
creasing the risk of cognitive impairment and dementia. Our 
objective was to analyze the prevalence of dementia and the 
associated factors in Latin American older adults during 
SARS-CoV-2 pandemic. Methods: A multicentric first phase 
cross-sectional observational study was conducted during 
the SARS-CoV-2 pandemic. Five thousand two hundred and 
forty-five Latin American adults over 60 years of age were 
studied in 10 countries: Argentina, Bolivia, Chile, Colombia, 
Ecuador, Guatemala, Mexico, Peru, the Dominican Republic, 
and Venezuela. We used the telephone version of Montreal 
Cognitive Assessment, the “Alzheimer Disease 8” scale for 
functional and cognitive changes, and the abbreviated ver-
sion of the Yesavage depression scale. We also asked for so-
ciodemographic and lockdown data. All the evaluation was 
made by telephone. Cross-tabulations and χ2 tests were 
used to determine the variability of the prevalence of impair-
ment by sociodemographic characteristics and binary logis-
tic regression to assess the association between dementia 
and sociodemographic factors. Results: We observed that 
the prevalence of dementia in Latin America is 15.6%, vary-
ing depending on the country (Argentine = 7.83 and Bolivia 
= 28.5%). The variables most associated with dementia were 
race and age. It does not seem to be associated with the pan-
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demic but with social and socio-health factors. Conclusion: 
The prevalence of dementia shows a significant increase in 
Latin America, attributable to a constellation of ethnic, de-
mographic, and socioeconomic factors.
© 2021 The Author(s).
Published by S. Karger AG, Basel
Introduction
The coronavirus today has caused >2 million deaths in 
the world [1]. Some Latin American countries are among 
those that report the highest number of infections and 
deaths from the pandemic (Brazil, Argentina, and Peru). 
The poor implementation of intermediate and intensive 
care units, the lack of mechanical ventilators and oxygen, 
and an inefficient vaccine program; dramatically in-
creased the number of deaths in many Latin American 
countries [2].
This health crisis has severely impacted all age-groups 
but with much greater force in the elderly [3]. During the 
restriction measures due to the pandemic, medical and 
hospital care services were suspended, as well as comple-
mentary nonpharmacological, physical, social, and cog-
nitive intervention services. In some countries, there have 
been implemented telemedicine services, which have 
helped many older adults in the clinical follow-up [4]. 
Unfortunately, these services have not been implemented 
in all countries or have not had homogeneous coverage 
[5]. Despite this, the first reports showed higher indica-
tors of mood alterations [6, 7], complaints of cognitive 
decline [8], and increased consultations for neuropsychi-
atric problems [9, 10].
As we can see, restrictions in their daily activities, to-
gether with the indicators of more precarious health [11] 
and the impact on the well-being because the pandemic, 
could increase significantly the risk of developing demen-
tia [12]. Previous studies in Latin America have shown 
ranges of dementia between 1.8% and 11.5% [13, 14]. Re-
cent reviews show that the global prevalence of dementia 
for the region is 11%, which is higher than that registered 
in other parts of the world [15]. This prevalence is influ-
enced by an important combination of ethnic, risk factors 
(e. g., low educational level and age), and socioeconomic 
factors [16]. At the moment, we do not know the preva-
lence of dementia during the COVID-19 pandemic in 
Latin America.
As it may be observed, the risk of dementia could in-
crease significantly in Latin America during the pandem-
ic, associated not only with well-known risk factors but 
also with emotional and sociodemographic factors. To 
date, no studies have been reported showing the preva-
lence of dementia in the context of a pandemic and the 
associated sociodemographic factors. Therefore, we have 
proposed to analyze the prevalence of dementia and the 
main associated factors in older Latin American adults 
during the SARS-CoV-2 pandemic.
Materials and Methods
Study Design and Sampling
The study reports the findings of a first phase cross-sectional 
observational study (screening), carried out during the SARS-
CoV-2 pandemic in 5,245 Latin American older adults over 60 
years of age in 10 countries: Argentina, Bolivia, Chile, Colombia, 
Ecuador, Guatemala, Mexico, Peru, the Dominican Republic, and 
Venezuela. The sampling was nonprobabilistic and was obtained 
from private and public clinics and associations of older adults. 
The exclusion criteria were not been testing positive for SARS-
CoV-2 infection, prior clinical diagnosis of dementia or mild cog-
nitive impairment, and without clinical diagnosis of depression or 
anxiety during the lockdown period (shown in Fig. 1).
Procedure
A group of Latin American researchers and clinicians was 
formed in April 2020. Between April and May, the measures and 
protocols to be used were designed, prepared, and tested. The pro-
tocol included cognitive, functional, and emotional evaluations 
and was piloted in May 2020 with 680 participants. Minor chang-
es in linguistic and cultural adaptations were made (e.g., “pieza” 
[room] in Chile). Simultaneously, study directors together with 
the country coordinators trained the interviewers in the formats 
and surveys of the protocol, in addition to the use of the platform 
to complete the data. All the processes were made online, and every 
interviewer sends their first full protocol and received a personal 
feedback from country coordinator. All participants completed 
about 40 min of individual evaluation via telephone. Additionally, 
we evaluated a family member with functional and cognitive tests. 
The evaluations were carried between July and October 2020. We 
used the National Institute of Aging criteria for dementia [17] and 
were carried out in 2 phases. A first one was of screening, consid-
ering the cutoff points of the telephone version of Montreal Cogni-
tive Assessment (T-MoCA) [18], and “Alzheimer Disease 8” 
(AD8) [19]. A second part consisted of the review and validation 
of the presumptive diagnosis by neuropsychologists and neurolo-
gists.
Instruments
Participants completed sociodemographic, clinical, lifestyle, 
mood, cognitive, and functional questionnaires, in addition to in-
formation associated with the quarantine. For the evaluation of the 
emotional state, we used the abbreviated version of the Yesavage 
geriatric depression scale [20], which has shown acceptable indica-
tors of validity for the detection of mood alterations [21]. We used 
a cutoff level of 2 points to considered indicators of emotional dis-
turbance.
For the cognitive assessment, we elected the T-MoCa, which 
has shown important indicators of sensitivity and specificity for 
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cognitive alterations [18] and an important concurrent validity 
with the full version [22]. In Latin America, the MoCa test is the 
more frequently brief cognitive test used in clinical settings [23]. It 
contains 5 items that assess memory, fluency, and orientation. The 
cutoff level of 11 points has been considered.
Additionally, we used the AD8 to evaluate changes in cognitive 
and functional domains usually altered in dementia syndrome 
[24]. It has shown a high degree of sensitivity to cognitive impair-
ment when applied to caregiver [19] and adequate when self-com-
pleted [25]. The cutoff point of 2 points has been considered [19]. 
Finally, we used a questionnaire about the quarantine that includ-
ed items of level of accomplish, days in quarantine, and beginning 
day of lockdown, which varies according to the country and the 
propagation of the SARS-CoV-2 virus in the region.
Statistical Analysis
Descriptive statistics were used to indicate the most representa-
tive sociodemographic characteristics as well as the scores ob-
tained in the cognitive and functional measurements. We obtained 
the data of deterioration prevalence considering the cutoff points 
of the T-MoCa and AD8. Once the prevalence percentages were 
obtained, cross-tabulations and χ2 tests were performed to deter-
mine the variability of the prevalence of deterioration due to so-
ciodemographic characteristics. Finally, binary logistic regression 
was applied to evaluate the association between cognitive impair-
ment and sociodemographic factors, adjusted for age, years of 
schooling, and the Yesavage scale score. The analyses were per-
formed with the SPSS 25 statistical software synchronized with 
JASP. The significance level used was p < 0.05.
Ethical Considerations
All procedures contributing to this work complied with the 
ethical standards of the relevant National and Institutional Com-
mittees on human experimentation and considering the Declara-
tion of Helsinki. All participants or familiar/caregiver were in-
formed of the study and gave their consent online. The research 
was approved by the Ethics Committee of the coordinate institu-
tion of the project, The Universidad de la Costa (Act no.: 080, re-
search project code: INV.140-02-003-15).
Results
Sociodemographic and Quarantine Characteristics of 
the Participants
The final sample included 5,245 participants. The age 
range of the sample was between 60 and 94 years old, with 
a mean of 69.61 (SD = 7.28). Almost a third of the total 
sample was women (67%), with the exception of Peru, 
which exhibits more homogeneous indicators. The high-
est proportion of race was Latin American mestizo 
(55.1%), which varies depending on the country (Argen-
tina, 1.2%; Peru, 86.9%), and white (39.4%) with ranges 
between 8.9% for Peru and 98.8% for Argentina. More 
than half of the participants are married (52.3%). Like-
wise, the level of education achieved was mostly high 
school (38.7%), followed by technical formation (25%). 
Regarding the pandemic, almost all of the subjects report-
ed having been in quarantine (86.1%) and >70% reported 
having complied duly with the official confinement mea-
sures (see Table 1).
Prevalence of Dementia Globally and by Country
Table 2 shows that the prevalence of dementia for the 
total sample is 15.6%. We observe that Bolivia and Peru 
have the highest frequencies of deterioration (28.5% and 
Excluded (n = 655)
• Positive testing for Sars-Cov-2 (n = 232)
• Prior diagnosis of dementia (n = 108)
• Prior diagnosis of depression (n = 177)
• Hearing problems (n = 148)
Excluded (n = 440)
• Inconsistent data (n = 129)
• Without interview with familiar or







Fig. 1. Flow diagram showing patient in-
volvement.
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24%, respectively), while Argentina and Mexico show the 
lowest (7.83% and 10.34%, respectively).
Prevalence of Dementia by Age, Sex, and Race
We observe that cognitive impairment varies signifi-
cantly by age and race. Specifically, we see that dementia 
is higher in older participants, reaching 52.8% among 
adults between 90 and 94 years old, while in the 60–64 
age-groups, it is 9.6%. Likewise, we see that the prevalence 
of dementia is higher among Latin American Indian peo-
ple (34.7%) than the other racial groups (see Table 3).
Risk Factors for Dementia
Multivariate analysis reveals that the risk of demen-
tia (odds ratio) in African Americans is 2.2 times high-
er and in Latin American Indians it is 1.8 times higher 
than in the other participants. Likewise, we see that at 
an older age the probability increases significantly. Sub-
jects between 65 and 69 years are 1.3 times more likely 
to have dementia, while those between 90 and 94 years 
are 9.5 times more likely. Similarly, we found that the 
emotional state increases the risk by 1.2 times. The 
analysis by country shows that there is a higher proba-
bility of CI in participants from Bolivia (4 times higher 
risk), Guatemala (2.9 times higher risk), Peru (2.6 times 
higher risk), and Ecuador (2.1 times higher risk) to a 
lesser extent, Chile (1.6) and Venezuela (1.7). Finally, 
we observed that quarantine did not increase the risk of 
cognitive impairment in the sample studied (see Ta-
ble 4).
Discussion
Our purpose was to analyze the prevalence of demen-
tia in Latin America during the SARS-CoV-2-associated 
pandemic. Our results show a global prevalence of 15.6% 
of presumptive cases of dementia in older adults without 
COVID-19 infection, varying according to the country 
(higher prevalence in Bolivia and Peru and lower in Ar-
gentina and Mexico). In addition, we observed an impor-
tant relationship with age, level of education, ethnicity, 
and emotional state.
The prevalence found is higher than that reported in 
other studies [13, 15]. Specifically, Zurique found preva-
lence with ranges between 2% and 42%, which varied ac-
cording to the type of study, age of the sample, and diag-
nostic criteria. Likewise, Nitrini et al. [13] reported a stan-
dardized prevalence of 7.1 (ranges between 2.66 and 
12.16) but that it increased significantly among illiterates 
(total prevalence: 15.67, ranges between 5.03 and 36.06). 
In both cases, a significant variability was observed be-
tween countries.
Our data also show important difference between 
countries. The highest prevalence is found in those coun-
tries where social and health systems are the weakest in the 
region (Bolivia, Peru, and Guatemala) and have indicators 
of higher health risk such as being overweight or even ba-
sic sanitation [26] but also in those that show a higher 
proportion of the aging population (Chile) [27]. As we can 
see, Latin America is one of the regions with the highest 
indicators of inequality in access to health care. Inhabi-
tants with low socioeconomic status, from rural areas and 
of different ethnic groups, have very limited access to care 
and indicators of higher health risk [26]. These factors, 
together with those associated with the pandemic (isola-
tion, greater health neglect), are leading to a major health 
crisis among older adults, which as we see is exacerbating 
emotional and cognitive alterations [28].
On the other hand, the data show that the risk of de-
mentia increases significantly with advancing age. We 
observe that the risk can be 9 times higher among adults 
aged 90–95 years than between 60 and 64 years. Epide-
miological studies have consistently described this pat-
tern [29]. On the other hand, years of schooling have been 
shown to be a protective factor in different studies [30]. 
This could be associated with the cognitive reserve effect 
generated by having higher levels of schooling [31]. How-
ever, in Latin American samples, years of schooling seem 
not to be a good predictor of cognitive performance [32] 
due to the enormous variability in educational quality in 
the region.
Table 2. Prevalence of dementia by country and total




Argentina 471 (92.17) 40 (7.83)
Bolivia 404 (71.50) 161 (28.50)
Chile 396 (83.90) 76 (16.10)
Colombia 620 (87.08) 92 (12.92)
Ecuador 364 (83.49) 72 (16.51)
Guatemala 282 (82.94) 58 (17.06)
Mexico 581 (89.66) 67 (10.34)
Peru 457 (76.04) 144 (23.96)
Dominican Republic 339 (88.28) 45 (11.72)
Venezuela 513 (89.06) 63 (10.94)
Total sample 4,427 (84.40) 818 (15.60)
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Likewise, we observed that ethnicity has a significant 
relationship with a greater probability of deterioration, 
especially in African Americans and Latin American 
Indians. These results have been seen in studies with 
ethnic minorities [33, 34] and also in population studies 
in Latin America [35]. These results could be associated 
with factors linked to the social determinants of health, 
which combine a series of factors that include a low ed-
ucational level, greater vascular problems (more cases 
of diabetes and hypertension), poor eating habits, 
among others, and that have shown an important effect 
on health [16]. Finally, we see that the emotional state 
has a significant impact on the risk of cognitive impair-
ment. As we have seen previously, there is an important 
effect of the pandemic overemotional state [6] and an 
altered cognition, as founded in the longitudinal study 
[36]. It has been considered as a preclinical phase of de-
mentia [37].
It is interesting to note that the factors associated with 
the pandemic (days of quarantine and the level of accom-
plish) did not seem to affect the cognitive state of the sam-
ple studied. This could be associated with the level of 
compliance with the government’s measures, which in 
many countries was not total. The need to carry out ac-
tivities to generate economic income, due to the high de-
gree of informality of the economy [38] and given that the 
majority of Latin American older adults live with their 
family [39], led to maintaining some levels of activity, 
providing them emotional support during quarantine.
Despite the interesting results found, this study is not 
exempt of limitations. In first place, considering that it is 
a cross-sectional study based on the cutoff points of the 
screening tests and clinical judgment for diagnosis, it is 
possible to fall in misdiagnosis. However, we have taken 
the gold standard criteria for dementia diagnosis [17] and 
follow the guidelines of the handbook for best practices 
in dementia diagnosis in the Latin America region [40]. 
Therefore, it is essential to monitor the sample and cor-
roborate the diagnosis. Second, it is important to validate 
the instruments used. The MoCa test is one of the most 
widely used instruments in Latin America [23, 41] but its 
use has been extended to the pencil and paper version. 
The short version and application via telephone or tele-
medicine (T-MoCa) have not yet been validated in the 
region. Despite this, studies in other contexts [42] have 
shown significant convergent validity of the full version. 
On the other hand, in the case of AD8, we used the crite-
ria of the Cochrane review [43] and the Chilean version 
as a reference [19]. Therefore, its validation is necessary 
in the other countries of the region.
These psychometric aspects of the instruments are 
fundamental, especially in the current pandemic cir-
cumstances where telemedicine and teleneuropsychol-
ogy have become important for the monitoring and 
Table 3. Prevalence of dementia by age, sex, and race
Without dementia, n (%) With dementia, n (%) χ2
Age-group
60–64 1,384 (90.39) 147 (9.60) 258.270**
65–69 1,241 (87.58) 176 (12.42)
70–74 894 (85.55) 151 (14.45)
75–79 522 (78.38) 144 (21.62)
80–84 261 (72.50) 99 (27.50)
85–89 108 (56.84) 82 (43.16)
90–94 17 (47.22) 19 (52.78)
Gender
Male 1,511 (85.08) 265 (14.92) 0.928
Female 2,916 (84.06) 553 (15.94)
Race
White 1,720 (86.65) 265 (13.35) 42.240**
African American 52 (82.54) 11 (17.46)
Latin American mestizo 2,473 (83.63) 484 (16.37)
Latin American indigenous 77 (65.25) 41 (34.45)
Another 105 (86.07) 17 (13.93)
** p < 0.001.
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evaluation of older adults. They could also help gener-
ate protocols to serve the rural population and ethnic 
minorities that do not have access to specialists in cog-
nitive impairment [44]. On the other hand, it is neces-
sary to increase the representativeness of ethnic minor-
ities and rural areas. Our results show a higher preva-
lence of dementia in ethnic minorities but the sample 
size is low and the presence of many confounding fac-
tors is high. Finally, it would be convenient to analyze 
the positive cases for COVID and assess the conse-
quences in the medium- and long-term. Recent reviews 
show neurological alterations [45], so it is important to 
monitor this population group.
Conclusions
We can conclude that the prevalence of cognitive im-
pairment shows a significant increase in Latin America, 
which varies depending on the country. The variables 
most associated with this increased risk are race, gender, 
and age but it seems not to be associated with the pan-
demic and if it is associated with social and socio-health 
factors. This first multicenter study in the context of a 
pandemic shows the need to follow-up older adults and 
provide contexts for evaluation, monitoring, and inter-
vention to avoid a significant increase in cases. Further-
more, it highlights the importance of conducting multi-





p value 95% confidence interval 
(odds ratio scale)
Ages of schooling 0.008 0.907 <0.001 0.892 0.923
Yesavage 0.031 1.248 <0.001 1.176 1.328
Race
Whites (RC)
African American 0.375 2.143 0.028 1.074 4.708
Latin American mestizo 0.107 0.868 0.184 0.704 1.070
Latin American indigenous 0.242 1.818 0.013 1.131 2.920
Another 0.315 0.757 0.377 0.408 1.405
Age-group
60–64 (RC)
65–69 0.131 1.324 0.033 1.023 1.713
70–74 0.138 1.396 0.017 1.061 1.824
75–79 0.143 2.161 <0.001 1.629 2.868
80–84 0.164 3.140 <0.001 2.271 4.342
85–89 0.191 4.944 <0.001 3.385 7.220
90–94 0.378 9.591 <0.001 4.753 20.113
Quarantine compliance
Not at all (RC)
Slightly 0.734 2.087 0.316 0.495 8.802
Somewhat 0.685 2.785 0.135 0.727 10.674
Sufficient 0.669 2.834 0.119 0.764 10.509
All the time 0.666 3.027 0.096 0.821 11.157
Gender (female) 0.095 0.840 0.067 0.701 1.016
Country
Argentina (RC)
Bolivia 0.216 4.092 <0.001 2.677 6.254
Chile 0.246 1.644 0.044 1.012 2.671
Colombia 0.224 1.470 0.087 0.986 2.376
Ecuador 0.237 2.158 0.001 1.354 3.441
Guatemala 0.244 2.961 <0.001 1.834 4.780
Mexico 0.238 1.181 0.483 0.742 1.882
Peru 0.220 2.618 <0.001 1.696 4.043
Dominican Republic 0.256 1.638 0.081 0.991 2.707
Venezuela 0.228 1.719 0.018 1.099 2.688
RC, reference category.
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national studies that allow us to standardize criteria for 
evaluation, diagnosis, and follow-up.
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